Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
07/2004
07/15/2004US20040138282 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
07/15/2004US20040138279 Imidazole derivatives as phosphodiesterase VII inhibitors
07/15/2004US20040138250 Inhibitors of cruzipain and other cysteine proteases
07/15/2004US20040138242 Dihydropyrimidines and uses thereof
07/15/2004US20040138230 Psychological and central nervous system disorders; alzheimer's disease; Huntington's disease
07/15/2004US20040138227 Antiserotonine agents; antidepressants
07/15/2004US20040138222 Post-trauma stress disorder, attention deficit disorders, obsessive compulsive disorders; anxiolytic agents; eating disorders; premenstrual disordrers
07/15/2004US20040138219 Quinolines and nitrogenated derivative therof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
07/15/2004US20040138196 Salinosporamides and methods for use thereof
07/15/2004US20040135871 Indolylphthalide compound and thermal recording material using the same
07/15/2004CA2509510A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
07/15/2004CA2485375A1 Spirocyclic piperidines as mch1 antagonists and uses thereof
07/14/2004EP1437346A1 Benzamide derivatives useful as cell differentiation inducers
07/14/2004EP1437132A1 Use of nitric ester derivatives in the manufacture of a medicament for the treatment of gastrointestinal tumors
07/14/2004EP1436298A1 Himbacine analogues as thrombin receptor antagonists
07/14/2004EP1436296A2 Process for the direct preparation of pyrrolo 3,4-c]pyrroles
07/14/2004EP1436293A1 Polycyclic compounds having anti-tumor activity
07/14/2004EP1436287A2 Small organic molecule regulators of cell proliferation
07/14/2004EP1235803B1 Urea compounds having muscarinic receptor antagonist activity
07/14/2004CN1513176A Optical data carrier that contains triazycyanine dye as light-absorbing compound in the information layer
07/14/2004CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer
07/14/2004CN1513174A Optical data carrier containing axially substituted co-phthalocynine in the information layer that can be written with light
07/14/2004CN1513173A Optical data carrier containing a cyclizable compound in the information layer
07/14/2004CN1513172A An optica data storage medium containing diaze hemicyanine dye as light-absorbing compound in infomration layer
07/14/2004CN1513171A Optical data carrier containing dye in the information layer as light-absorbing compound
07/14/2004CN1512995A Novel ligand for nicotinic acety/choline receptors useful in therapy
07/14/2004CN1157396C Process for production of levo-ofloxacin
07/14/2004CN1157394C Dihydrofuro [3,4-b] quinoline-1-ketone type compound, its preparation method and medicinal composition containing these compounds
07/14/2004CN1157379C Tetrahydroquinoline derivatives
07/14/2004CN1157378C Qunoline derivatives
07/13/2004US6762301 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
07/13/2004US6762191 Therapeutic compounds
07/08/2004WO2004056797A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
07/08/2004WO2004056747A1 Dhodh-inhibitors and method for their identification
07/08/2004WO2004056746A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
07/08/2004WO2004056398A1 Isotope labeled camptothecin derivatives
07/08/2004WO2004056369A1 Benzo ‘ d!azepine derivatives for the treatment of neurological disorders
07/08/2004WO2004029578A3 Energy transfer dyes, terminators and use thereof
07/08/2004US20040132781 Pyrazole compounds useful as protein kinase inhibitors
07/08/2004US20040132752 cyclic ureas and triazolones; treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia.
07/08/2004US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
07/08/2004US20040132714 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
07/08/2004US20040132710 Lactams as tachkinin antagonists
07/08/2004US20040132693 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE)
07/08/2004CA2509418A1 Isotope labeled camptothecin derivatives
07/08/2004CA2509138A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
07/07/2004EP1401431A4 Human growth hormone antagonists
07/07/2004EP1073435B1 Substituted tricyclic pyrazole derivatives with protein kinase activity
07/07/2004CN1511192A Production of polyketides
07/07/2004CN1511161A Novel tricyclic dikydro-quinolin derivatives, method for preparing same and pharmaceutical compositions containing same
07/07/2004CN1511159A Nitrogen-based camptothecin derivatives
07/07/2004CN1511158A Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
07/07/2004CN1511154A Quinuclidines-substituted-multi-cycli-heteroaryls for treatment of disease
07/07/2004CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives
07/07/2004CN1511141A Method for preparation of 10,11-dihydro-10-hydroxy-5H-dibenz/B, F/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B, F/azepine-5-carboxamide
07/07/2004CN1156470C New Substituted pyridyl keto enols
07/07/2004CN1156446C Indenoindolone compounds, their preparation and medicinal compositions containing them
07/06/2004US6759548 Dialkyl-halogenophenyl-substituted ketoenols
07/06/2004US6759416 Such as 10-(4-((4-(4,7,10,13,16,19-docosahexenoyl)amino)-benzyl)-1 -piperazino)carbonyl-oxycamptothecin
07/06/2004US6759409 Inhibitors of papilloma virus
07/01/2004WO2004055019A1 Method of making tricyclic aminocyanopyridine compounds
07/01/2004WO2004055015A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/01/2004WO2004055004A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
07/01/2004WO2004055003A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
07/01/2004WO2004054505A2 Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors
07/01/2004WO2004054504A2 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/01/2004WO2004037170A3 Process for making spirolactone compounds
07/01/2004WO2004026819A3 OPIATE ANALOGS SELECTIVE FOR THE delta-OPIOID RECEPTOR
07/01/2004WO2004018058A3 Compounds, compositions, and methods
07/01/2004US20040127714 Method of making tricyclic aminocyanopyridine compounds
07/01/2004US20040127713 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs
07/01/2004US20040127712 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors
07/01/2004US20040127711 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones
07/01/2004US20040127709 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
07/01/2004US20040127708 antiviral activities; aids treatment
07/01/2004US20040127540 its production by fermentation, to methods for its recovery and concentration from the crude solutions, and to a process for its purification
07/01/2004US20040127530 treating gram-negative microbial infections
07/01/2004US20040127527 Large conductance calcium-activated k channel opener
07/01/2004US20040127516 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines and the use of the same as analgesics
07/01/2004US20040127510 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
07/01/2004US20040127482 Substituted heterocycle fused gamma-carbolines
07/01/2004US20040127477 Heterocyclic glycyl beta-alanine derivatives
07/01/2004US20040127365 Arylphenyl-substituted cyclic ketoenols
07/01/2004CA2509665A1 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/01/2004CA2509249A1 Method of making tricyclic aminocyanopyridine compounds
07/01/2004CA2509244A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/01/2004CA2509239A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
07/01/2004CA2509233A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
07/01/2004CA2508780A1 Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors
06/2004
06/30/2004EP1433789A1 Pyrrolopyrazines and their use as selective apoptosis inducers
06/30/2004EP1432734A1 Cytokine receptor
06/30/2004EP1432715A2 Pyrimidine derivatives
06/30/2004EP1432707A1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
06/30/2004EP1432695A1 A process for the stereoselective synthesis of 2-hydroxymethyl-chromans
06/30/2004EP1432690A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
06/30/2004EP1432680A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
06/30/2004EP1237524A4 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
06/30/2004EP1178982B1 Heterocyclic substituted aminoazacycles useful as central nervous system agents
06/30/2004EP1019408B1 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES
06/30/2004EP0809629B1 2-phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides